From lab to listed: Turning Australian research into global impact.

Dr Andreas Fouras is an internationally recognised leader in medical technology and innovation, a reputation gained over a successful career that has cut across both academic research and the development of innovative medtech that is now delivering real-world clinical impact.
Upon completing his master’s course and attaining a PhD, Andreas had a short but successful career in academic research. Andreas held the positions of Professor of Mechanical and Aerospace Engineering and Director of the Laboratory for Dynamic Imaging at Monash University, where he led groundbreaking work in imaging, fluid dynamics and mechanobiology.

Andreas then entered the business world. He founded 4DMedical in December 2012, which subsequently listed on the ASX in August 2020 (ASX:4DX), and is now an S&P/ASX 200 company. He is today the company’s CEO and CTO.
Under Andreas’ leadership, 4DMedical developed CT:VQ™, the first and only FDA-approved technology that enables clinicians to image and quantify lung ventilation and perfusion without contrast media.

Andreas continues to leverage his experience at the intersection of developing and commercialising breakthrough solutions in respiratory medicine to generate a global impact on healthcare. This work is ensuring patients, clinicians, and healthcare systems benefit from diagnostic technologies that are more sensitive, less invasive and more accessible to wider populations.